Google
 

Archive for the ‘Liver Disease / Hepatitis’ Category

British Overseas Travellers Warned About High Risk Of Hepatitis, Association Of British Hujjaj (Pilgrims) UK

Thursday, February 21st, 2008

A team of senior doctors from the Association of British Hujjaj (Pilgrims) UK, a national charitable organisation, have issued a strong warning to British overseas travellers to South Asian countries and other developing countries that they must take extra care to protect themselves from infectious diseases like Hepatitis. The senior ...

Liver Damaged By Too Much Fast Food And Too Little Exercise

Friday, February 15th, 2008

A study published in the journal Gut reports thattoo much fast food and too little exercise can harm the liver. Swedish researchers selected 18 thin, healthy volunteers - 12 men and 6women - to attempt a 5 to 15% body weight increase by eating at leasttwo fast-food-based meals per day ...

SciClone And Sigma-Tau Report Promising Interim Results From Phase 3 Hepatitis C Trial

Tuesday, February 12th, 2008

SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) and Sigma-Tau S.p.A reported promising blinded interim data from a large, randomized phase 3 clinical trial evaluating ZADAXIN® (thymalfasin) in combination with pegylated interferon alpha and ribavirin as a treatment for patients with hepatitis C virus (HCV) who have not responded to prior therapy ...

AASLD Honours William F. Balistreri, M.D., With Distinguished Service Award

Saturday, February 9th, 2008

William F. Balistreri, MD, Editor of The Journal of Pediatrics, has been honored with the American Association for the Study of Liver Diseases (AASLD) 2007 Distinguished Service Award, recognizing his sustained commitment and contribution to the AASLD as well as to the liver disease community. He is the first pediatrician ...

Drive To Treat And Prevent Hepatitis C

Saturday, February 9th, 2008

Adelaide scientists will lead a $2 million five-year project to develop new vaccines and explore better treatment options for hepatitis C sufferers.University of Adelaide virologists Dr Michael Beard and Dr Karla Helbig will work with colleagues from the University of NSW to develop new strategies to treat and prevent hepatitis ...

California Bill Aims To Boost Culturally Appropriate Hepatitis B Prevention, Management, Expand Medicaid Coverage For Disease

Friday, February 8th, 2008

The California Assembly on Jan. 29 voted 46-16 to approve legislation (AB 158) that would require the state Department of Health Care Services to set up the Hepatitis B Prevention and Management Pilot Program Fund within the Office of Multicultural Health, Asian Week reports. The program would give grants to ...

Impact Of Donor Organ Allocation System Discussed By Mayo Clinic Proceedings Contributors

Thursday, February 7th, 2008

Liver transplant is a life saving treatment option for people with end-stage liver disease. Unfortunately, the need for donor livers far exceeds the supply. Each year only about one-third of people who need a donor liver will receive one, and some patients die while waiting. In the February issue ...

Hepatitis C Infection May Be Blocked By Grapefruit Compound

Tuesday, February 5th, 2008

A compound that naturally occurs in grapefruit and other citrus fruits may be able to block the secretion of hepatitis C virus (HCV) from infected cells, a process required to maintain chronic infection. A team of researchers from the Massachusetts General Hospital Center for Engineering in Medicine (MGH-CEM) report that ...

Studies Test Noninvasive Alternatives To Liver Biopsy

Monday, February 4th, 2008

Two new studies examine non-invasive ways to determine liver fibrosis and cirrhosis. An enhanced version of the Original European Liver Fibrosis panel was found to have good diagnostic accuracy for fibrosis in patients with non-alcoholic fatty liver disease. Conversely, transient elastography was unreliable for detecting cirrhosis in patients with acute ...

In Chronic Hepatitis C Silymarin Does Not Affect Virus Activity Or ALT Levels

Monday, February 4th, 2008

In a survey of patients with chronic hepatitis C who participated in a National Institute of Diabetes and Digestive and Kidney Diseases-sponsored long-term treatment trial for patients who had failed to respond previously to antiviral therapy, approximately 40% acknowledged to interviewers at the time of enrollment that they were currently ...

‘IDEAL’ Study Affirms Roche’s Pegasys As Effective Treatment For Hepatitis C

Thursday, January 17th, 2008

The announcement made by Schering-Plough on the early results of the IDEAL study affirms the importance of Pegasys (peginterferon alfa 2a) and Copegus (ribavirin) for the successful treatment of hepatitis C. The study demonstrates that Pegasys and Copegus treatment delivered a similar sustained virological response (SVR) - the ...

Advancements In Detecting And Diagnosing Biliary Atresia In Children May Improve Outcomes

Wednesday, January 9th, 2008

The most common indication worldwide for pediatric transplantation, biliary atresia is also the most common cause of chronic liver disease in newborns. Recently, Children's Hospital of Pittsburgh of UPMC physicians completed a review of issues that children with biliary atresia face that lead to the need for transplantation.Nationally about 42 ...

Moffitt Seeking Participants For Advanced Liver Cancer Study, USA

Wednesday, January 9th, 2008

If you have primary liver cancer that has spread to other organs or is too advanced to be treated by surgery, Moffitt Cancer Center is looking for you. You must not have had prior chemotherapy treatment. Hepatocellular carcinoma, or primary liver cancer, is the fifth most common type of tumor. ...

The Impact Of Hepatitis B On Quality Of Life

Monday, January 7th, 2008

With over 350 million people affected worldwide, infection with the chronic hepatitis B virus causes considerable distress to individuals and results in substantial global economic loss through costs of treatment and indirectly, through lost productivity. However, the impact on the quality of life of patients is not well studied ...

MRI Techniques Could Potentially Replace Liver Biopsy

Thursday, January 3rd, 2008

MRI imagery is emerging as a non-invasive way to determine the existence and extent of hepatic fibrosis. It could eventually help the development of pharmacologic strategies to combat the condition. These findings are in the January issue of Hepatology, a journal published by John Wiley & Sons on behalf of ...